The global anti-peptic ulcer drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Anti-peptic ulcer drugs are among the various classes of drugs with different action mechanisms used to treat or reduce peptic ulcers or irritation of the gastrointestinal tract. Further, H. pylori, the spiral-shaped bacteria can damage the stomach and duodenum lining and cause peptic ulcer disease. The market growth is majorly attributed to the exceptionally growing prevalence of peptic ulcers all over the globe. As per the National Institutes of Health (NIH), about 30 to 40% of people in the US get an H. pylori infection. In most cases, the infection remains dormant, or quiet without signs or symptoms, for years. Most people get an H. pylori infection as a child.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/anti-peptic-ulcer-drugs-market
Another key trend observed in the market includes the growing preference of patients toward peptic ulcer drugs over surgeries. This is anticipated to be a major factor to augment the global anti-peptic ulcer drugs market during the forecast period. In addition to this, the increasing focus of the key players of the market on the research and development activities coupled with the rising number of generic drugs manufacturers of peptic ulcer drugs are also likely to offer lucrative opportunities for market growth. Further, stressed lifestyles, as well as a significant rise in the patient pool with H. pylori infection, will also raise the demand for these drugs in the future years.
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/anti-peptic-ulcer-drugs-market
• Competitive Landscape: AstraZeneca plc, and Takeda Pharmaceutical Co., Ltd., among others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Anti-Peptic Ulcer Drugs Market Report by Segment
By Product Type
• Proton Pump Inhibitors
• Antacids
• Potassium-Competitive Acid Blockers (P-CAB)
• H2 Antagonist
• Others
By Application
• Gastritis
• Gastric Ulcers
• Duodenal Ulcers
• Gastroesophageal Reflux Disease (GERD)
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404